Abstract Cervical cancer prevention/control efforts among women living with HIV/AIDS (WLH) are socially and structurally challenging. Healthcare access and perceived HIV stigma and discrimination are factors that may challenge risk reduction efforts. This study examined socio-structural determinants of cervical cancer screening among women engaged in HIV care. One hundred fortyfive WLH seeking health/social services from AIDS Service Organizations in the southeastern US completed a questionnaire assessing factors related to cervical cancer prevention/control. Ninety percent were African American, mean age 46.15 ± 10.65 years. Eighty-one percent had a Pap test\1 year ago. Low healthcare access was positively associated with having a Pap test \1 year ago, (Odds ratio [OR] 3.80; 95 % Confidence interval [CI] 1.34-10.78). About 36 % reported C2 Pap tests during the first year after HIV diagnosis. Lower educational attainment was positively associated with having C2 Pap tests, OR 3.22; CI 1.08-9.62. Thirty-five percent reported more frequent Pap tests after diagnosis. Lower income was moderately associated with more frequent Pap tests post-diagnosis, OR 2.47; CI .98-6.23. Findings highlight the successes of HIV initiatives targeting socio-economically disadvantaged women and provide evidence that health policy aimed at providing and expanding healthcare access for vulnerable WLH has beneficial health implications.
Introduction
Early into the HIV/AIDS epidemic, the Centers for Disease Control and Prevention (CDC) identified cervical cancer as an AIDS-defining malignancy [1, 2] . Between 1980 and 2007, the incidence of cervical cancer among women living with HIV/AIDS (WLH) increased approximately 60 % [3] . The growing incidence of cervical cancer is attributed to the increase in HIV acquisition among women and substantial improvements in life expectancy [3, 4] . Compared to uninfected women, WLH have a sixfold increased risk of developing cervical cancer in their lifetime [3, 5] . This disparity is in part the result of persistent infection with high-risk (i.e., oncogenic) types of human papillomavirus (HPV) and the inability to clear HPV infections due to reduced immune function [6] . Although immune function may contribute to cervical cancer development among WLH, gaps in cancer screening also contribute to later stages of diagnosis and concomitantly higher rates of morbidity and mortality [6] [7] [8] [9] [10] [11] [12] [13] . The CDC recommends that WLH receive two Pap tests during the first year after diagnosis and annually thereafter [8] . Despite the Ryan White Program provision of medical care, including Pap tests, for uninsured and underinsured WLH, cumulatively 20-40 % of the population do not meet cervical cancer screening recommendations [8, [14] [15] [16] [17] .
Efforts to prevent and control cervical cancer among WLH are biologically, economically, socially, and behaviorally challenging [5, 7, [13] [14] [15] [18] [19] [20] [21] . Current scientific evidence suggest that awareness and knowledge [14, 18] , health literacy [15] , provider recommendation [19] , fear [18, 19] , and healthcare access [14, 20, 21] influence cervical cancer screening engagement. However, less is known about the impact of perceived stigma and discrimination on cervical cancer screening, factors that have been negatively associated with general health services utilization among WLH [22] [23] [24] [25] [26] . Moreover, there is a paucity of literature which attempts to understand the influence of access to care, stigma, and discrimination on care engagement among women engaged in HIV care. Given the vast contribution of healthcare access on cervical cancer disparities, understanding the influence of sociostructural factors on screening among women engaged in HIV care contributes to the scientific knowledgebase by providing valuable insight into the ways by which cervical outcomes can be maximized when access is directly or indirectly intervened upon. Thus, the purpose of this study was to examine social (e.g., perceived stigma and discrimination) and structural (e.g., healthcare access, transportation access, and source of care) determinants of cervical cancer screening engagement among WLH who are engaged in medical care or HIV-related social services.
Methods
Between March 2011 and April 2012, 145 WLH seeking healthcare from Ryan White-funded clinics and social services from community-based AIDS Service Organizations (ASOs) in two cities located in the southeastern United States (US) were recruited to participate in this study. Ryan White-funded clinics provide healthcare services to WLH, including Pap tests. ASOs refer WLH to health and social services, but do not provide direct clinical care. The recruitment sites were chosen because of the high HIV disease burden in the geographical areas [27] . Further, the selected areas are designated as medically underserved by the US Department of Health and Human Services, Health Resources and Services Administration [28] . As such, additional efforts to address health among WLH in these areas is of national importance.
Women were approached at the end of their visit at the respective recruitment site to discuss study participation and eligibility. Eligibility criteria included: (1) being female; (2) having an HIV/AIDS diagnosis; and (3) being C18 years of age. Women who provided consent to participate in the study were asked to complete an intervieweradministered questionnaire. The questionnaire assessed cervical cancer prevention knowledge, attitudes, beliefs, behaviors and social and structural level factors associated with care engagement. All interviews were conducted in a private room at the respective recruitment site. This study was approved by the University of South Carolina Institutional Review Board.
Measures

Cervical Cancer Screening Engagement
Our primary outcomes of interest, all associated with cervical cancer screening engagement, were adapted from the literature and previous work of the authors [15, 29, 30] . Three items were used to assess cervical cancer screening engagement: (1) 
Perceived HIV Stigma
To assess HIV stigma, we used a modified version of the HIV Cost and Services Utilization Study stigma scale [31] [32] [33] . Women were asked, ''Since you have had HIV, has anyone: (1) been uncomfortable with you, (2) treated you as an inferior, (3) preferred to avoid you, and (4) refused you service(s)'' (Cronbach's a = .84). Response options were Yes/No. For this study, a ''Yes'' response to at least one item was coded ''perceived stigma'' and a ''No'' response to all items was coded ''no perceived stigma''.
Perceived Healthcare Discrimination
To assess perceived healthcare discrimination, we adapted Williams et al. Everyday Discrimination Scale [34] . Participants were asked, ''How often has someone at your HIV treatment provider's office made you feel inferior or uncomfortable, treated you with disrespect, or given you poor care due to your: (1) Race or ethnicity?; (2) Income or education level?; (3) Health insurance?; and (4) HIV status?'' (Cronbach's a = .72). Response options were on a 5-point Likert scale: 1 = ''never'' to 5 = ''all of the time''. Items were summed to create a composite score with a maximize score of 20. Higher scores indicate greater perceived healthcare discrimination.
Healthcare Access
A seven-item scale adapted from the HIV Cost and Services Utilization Study was used to assess healthcare access covering the domains of affordability, availability, convenience, and accessibility, Cronbach's a = .83 [31] [32] [33] . Participants were asked to state their agreement with the following statements: (1) ''I have never gone without the medical care needed because it was too expensive''; (2) ''Places where I can get medical care are very conveniently located''; (3) ''I am able to get medical care whenever I need it''; (4) ''I have easy access to the medical specialists that I need'', (5) ''It is easy for me to get medical care in an emergency''; and (6) ''If I need hospital care, I can get admitted without any trouble''. Response options were on a 4-point Likert scale, ''1 = strongly agree'' to ''4 = strongly disagree''. Items were dichotomized into two categories, ''high healthcare access'' and ''low healthcare access''.
Transportation Access
To assess access to transportation, women were asked, How would you describe being able to get to medical appointments? Response option were on a 4-point Likert scale (i.e., very easy, easy, hard, very hard) and dichotomized into two categories, ''easy'' versus ''hard''.
Regular Source of Care
To assess non-HIV disease specific regular source of care, a modified version of the behavioral risk factors and surveillance system (BRFSS) healthcare access item was used [35] , ''Do you have someone else that you think of as your personal doctor or healthcare provider (that is, someone other than who you go to for your HIV care)?'' Response options were yes, no, and don't know. Response options were collapsed into two categories, ''Yes'' and ''No/Don't Know''.
Sociodemographics
Race, ethnicity, age, employment status (full time/part time vs. unemployed), income (\$10k/year vs. C$10k/year), education (no high school/GED, high school diploma/ GED, Csome college), and relationship status (single vs. married/living with partner) were obtained.
Data Analysis
Descriptive statistics summarized sociodemographic characteristics of study participants. Multivariable logistic regression was used to model the probability of having: (1) a Pap test \1 year ago; (2) C2 Pap tests after being diagnosed with HIV; and (3) having Pap test more often post HIV diagnosis. First, multivariable logistic regressions were conducted to determine sociodemographic (i.e., age, education, income, employment, and relationship status) predictors of the three cervical cancer screening outcome variables. Any sociodemographic variables significant at p B .20 in the first models were included in the final multivariable logistic regression models along with the main outcomes of interest (i.e., perceived HIV stigma, perceived healthcare discrimination, healthcare access, transportation access, and source of care). We understand that a p value of .20 deviates from the statistical significance standard of .05. However, to more effectively address confounding, we followed Vittinghoff et al. criterion for model building [36, 37] . Vittinghoff recommends retaining variables at the .20 level because a variable can be a confounder even if it does not reach statistical significance as an independent predictor of the outcome [36, 37] . A 95 % confidence interval (CI) for odds ratios (OR) indicated statistical significance. Nagelkerke R 2 values provided an indication of the amount of variation in cervical cancer screening engagement explained by each multivariable regression model and Hosmer-Lemeshow Test indicated a good model fit. All analyses were conducted in 2015 using SPSS 22.0.
Results
Sample Characteristics
One hundred forty-five participants completed the questionnaire. The majority were African American (90 %, n = 131) and non-Hispanic (96 %, n = 139), mean age 46.15 ± 10.65; range 20-68 years. About 26 % (n = 38) of participants were married/living with partner, 45 % (n = 65) completed Csome college, and 26 % (n = 38) were full or part-time employed. See Table 1 for a complete list of sociodemographic characteristics of the sample.
The majority (64 %, n = 93) of participants did not have a personal healthcare provider other than their HIV care provider. Half (n = 72) reported low access to healthcare and 15 % (n = 21) reported difficulties accessing transportation to get to medical appointments. About 43 % (n = 62) reported perceived HIV stigma and the mean score on the 20-point perceived healthcare discrimination scale was 4.80 ± 1.86.
Cervical Cancer Screening Engagement
The majority of participants (81 %, n = 118) reported having a Pap test \1 year ago. In the first logistic regression model including only sociodemographic variables, no variable was associated with most recent Pap and thus, none were included in the final regression model (Table 2) . Low healthcare access was positively associated with having a Pap test \1 year ago (OR 3.80; CI 1.34-10.78) in the final logistic regression model, v 2 (7, n = 122) = 3.93, p = .79 (Table 3 ). The final model explained 13 % of the variance in most recent Pap test.
Thirty-six percent (n = 52) of participants reported having C2 Pap tests during the first year after being diagnosed with HIV. Education and relationship status were associated with having C2 Pap tests at p B .20 in the first regression model and were subsequently included in the final regression model (Table 2 ). In the final regression model, not having a high school diploma/GED (OR 3.22; CI 1.08-9.62) was the only significant association of having C2 Pap tests in the first year after being diagnosed with HIV, v 2 (8, n = 121) = 10.68, p = .22 (Table 3) . The model explained 10 % of the variance in Pap test utilization in the first year after diagnosis.
Thirty-five percent of participants (n = 50) reported having Pap tests more often after being diagnosed with HIV. Education and income were the only sociodemographic variables associated at p B .20 with change in cervical cancer screening engagement post-diagnosis in the AA African American, AI/AN American Indian/Alaska Native first regression model and thus, were included in the final regression model (Table 2 ). In the final model, having an income \$10k/year (OR 2.47; CI .98-6.23) was moderately associated with having more frequent Pap tests after being diagnosed with HIV, v 2 (7, n = 107) = 10.45, p = .17 (Table 3 ). The final model explained 10 % of the variance in Pap test frequency.
Discussion
This study aimed to understand the influence of social and structural factors on cervical cancer screening engagement among women engaged in HIV care. The majority of women reported meeting the Medicine Association of the Infectious Diseases Society of America annual cervical cancer screening recommendation [8] . The screening prevalence among women in this study is comparable to other studies examining screening behaviors among WLH [21, 38] . Despite the high prevalence of screening, about 20 % did not meet the annual screening recommendation. As these women are already engaged in HIV care through Ryan White-funded clinics and ASOs, this finding is particularly troubling. Improvements in health outcomes for WLH can only be fully realized if women access the services necessary to prolong and sustain a good quality of life. Identifying innovative communication channels and psychoeducational approaches to engage WLH who are connected to care, but not engaged in cervical cancer screening are central to impacting cervical cancer health disparities among women at highest risk for poor outcomes [30] .
Healthcare access, transportation access, perceived HIV stigma and healthcare discrimination, and source of care did not consistently predict cervical cancer screening engagement across screening behaviors. The only screening behavior associated with the aforementioned factors was having an annual Pap test. Women who reported having low access to healthcare were four times more likely to report meeting the annual screening recommendation. This finding is in contrast to other studies that have found a negative association between low healthcare access and health services utilization [39, 40] . However, in the current study this finding is not surprising given the recruitment of women already engaged in HIV care. Further, we found that WLH with lower educational attainment were three times and lower income were two times more likely to report meeting the recommended Pap test guidelines. We postulate that socio-economically disadvantaged women have more resources available to them through community outreach efforts and free or low cost health services. Further, these women may be continually forced to identify viable healthcare resources and thus, may be more familiar with the bureaucracy of obtaining care and better able to overcome such barriers. Despite reporting difficulties with healthcare affordability, availability, convenience, and accessibility, these women were able to overcome such obstacles and engaged in screening. Such findings are promising and suggest that HIV medical and social services intended to reach the most vulnerable population of WLH are empowering and better enabling women to reach their full health potential. The sociodemographic profile of WLH in this study was primarily African American, under-educated, and economically disadvantaged. At the state level, African Americans women comprise 81 % of all WLH [27] . As [41, 42] . Similarly, 65 % of participants in the current study reported being unemployed compared to 62 % of PLWHA at the national level [41] . A higher proportion of participants in the current study reported an income \10K compared to national data, 58 versus 35 % respectively [41] . Largely, the sociodemographic characteristics of women in this study is comparable to the national profile. The profile of PLWHA in the US reinforces the need to address the social determinants of health with increased emphasis on health services utilization. Undoubtedly, multi-level efforts will have the greatest impact on reducing the burden of HIV infection and improving health outcomes.
There are limitations to the study that should be considered when interpreting the results. First, all data were self-reported, which may have introduced recall bias and reporting error. Specifically, cervical cancer screening behaviors were not verified by medical chart review, therefore subject to recall bias. Some studies have found lower rates of cervical cancer screening utilization when assessed through a review of medical charts [43] [44] [45] , whereas others have found dependable agreement [46] . Second, we did not assess human papillomavirus (HPV) testing. As the higher incidence of cervical cancer among WLH is related to persistent infection with high-risk (i.e., oncogenic) types of HPV [6] , understanding and addressing barriers to HPV-testing and vaccination are equally important to combating cervical cancer disparities. Third, the measures used to assess HIV stigma and healthcare discrimination may not have fully captured theses complex constructs, despite acceptable reliability. Identifying alternatives measures or expanding upon currently available measures in attempts to more fully capture complex social constructs has substantial public health value. Fourth, this study was conducted among a predominantly African American sample of WLH residing in the southeastern US. As such, findings may not be generalizable to other racial/ ethnic groups of WLH or geographical regions. However, given the comparable sociodemographic profile as noted above, we are confident about the generalizability of our study findings both at the state and national level. Lastly, we recruited WLH from Ryan White funded-clinics and ASOs. Given the sample size, we were unable to conduct separate analyses by clinic and non-clinic recruitment. Thus, our ability to fully capture the influence of healthcare access on cervical cancer screening engagement among women engaged in care versus connected to care was limited. Further, we did not collect information on the sociocultural environment of the clinical recruitment site. Thus, we were unable to assess the preexisting sociocultural climate of the clinics with regard to stigma and discrimination, which may directly or indirectly influence cervical cancer screening engagement.
Conclusions
The Pap test is a public health innovation that has drastically reduced cervical cancer incidence and mortality. However, this innovation can only be realized if women consistently engage in recommended screening in a supportive environment conducive to such engagement. Identifying mechanisms to engage WLH who are not engaged in cervical screening offers a public health opportunity to maximize the innovation of the Pap test. Overall, HIV stigma and discrimination did not predict cervical cancer screening engagement and the influence of healthcare access as a predictor of engagement, although reasonable given our recruitment methodology, contrasted with the available literature. Study findings suggest that additional efforts should focus on WLH who have adequate access to care to ensure that the innovation of the Pap is not merely realized by some, but all WLH. Utilizing community health workers to promote cervical cancer screening and continued health services utilization for WLH should prove most effective [47] .
Additionally, follow-up research among women who did not meet the annual cervical cancer screening recommendation would better enable the medical and public health communities to address screening determinants among WLH who are most at risk for poor cervical cancer outcomes. Given the study's methodological design, we cannot conclude with certainty that HIV stigma and healthcare discrimination do not influence cervical cancer screening engagement among WLH. However, understanding the ways in which HIV stigma and discrimination exists and is perpetuated in communities and healthcare infrastructure can largely aid efforts to promote and sustain health services utilization. Lastly, capitalizing on opportunities to promote comprehensive health among women engaged in HIV care, but not cancer screening, should be a pivotal focus for the public health and medical communities. Cumulatively, study findings highlight the potential and successes of HIV initiatives to reach and engaged socioeconomically disadvantaged women with suboptimal access to healthcare. Nonetheless, public health initiatives must continue to target vulnerable women and identify way to reengaged those that are not receiving comprehensive healthcare.
